Charlie Lees (@charlie_lees) 's Twitter Profile
Charlie Lees

@charlie_lees

I write about inflammatory bowel disease providing inspiration, education and deep community. I am Professor of Gastroenterology and UKRIFLF. I also run a lot.

ID: 149989611

linkhttps://charlielees.substack.com calendar_today30-05-2010 19:30:36

8,8K Tweet

19,19K Followers

2,2K Following

Charlie Lees (@charlie_lees) 's Twitter Profile Photo

Adalimumab & ustekinumab equally effective in bionaive Crohn's disease No difference across multiple endpoints after 52 weeks Both drugs highly effective: early therapy is key in CD Big missed opportunity with SEAVUE - no long-term data coming ... would love to see 2y outcomes

Adalimumab & ustekinumab equally effective in bionaive Crohn's disease

No difference across multiple endpoints after 52 weeks

Both drugs highly effective: early therapy is key in CD

Big missed opportunity with SEAVUE - no long-term data coming ... would love to see 2y outcomes